167 related articles for article (PubMed ID: 32052612)
41. Protoporphyrin IX formation after topical application of methyl aminolaevulinate and BF-200 aminolaevulinic acid declines with age.
Nissen CV; Philipsen PA; Wulf HC
Br J Dermatol; 2015 Sep; 173(3):760-6. PubMed ID: 25997508
[TBL] [Abstract][Full Text] [Related]
42. In vivo measurement of 5-aminolaevulinic acid-induced protoporphyrin IX photobleaching: a comparison of red and blue light of various intensities.
Nadeau V; O'Dwyer M; Hamdan K; Tait I; Padgett M
Photodermatol Photoimmunol Photomed; 2004 Aug; 20(4):170-4. PubMed ID: 15238094
[TBL] [Abstract][Full Text] [Related]
43. Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy.
Ascencio M; Collinet P; Farine MO; Mordon S
Lasers Surg Med; 2008 Jul; 40(5):332-41. PubMed ID: 18563777
[TBL] [Abstract][Full Text] [Related]
44. Side effects of intra-gastric photodynamic therapy: an in vitro study.
Faraoni P; Gnerucci A; Ranaldi F; Orsini B; Romano G; Fusi F
J Photochem Photobiol B; 2018 Sep; 186():107-115. PubMed ID: 30029036
[TBL] [Abstract][Full Text] [Related]
45. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
46. Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.
Juzeniene A; Iani V; Moan J
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):538-45. PubMed ID: 24284108
[TBL] [Abstract][Full Text] [Related]
47. Comparative study of phototoxicity of protoporphyrin IX synthetic and extracted from ssp Rattus novergicus albinus rats toward murine melanoma cells.
Reis ER; Ferreira LP; Nicola EMD; Borissevitch I
Eur Biophys J; 2018 Sep; 47(6):601-609. PubMed ID: 29453611
[TBL] [Abstract][Full Text] [Related]
48. Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall.
Middelburg TA; de Bruijn HS; Tettero L; van der Ploeg van den Heuvel A; Neumann HA; de Haas ER; Robinson DJ
J Photochem Photobiol B; 2013 Sep; 126():26-32. PubMed ID: 23892187
[TBL] [Abstract][Full Text] [Related]
49. Photodynamic application of protoporphyrin IX as a photosensitizer encapsulated by silica nanoparticles.
Makhadmeh GN; Abdul Aziz A
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1043-S1046. PubMed ID: 30449196
[TBL] [Abstract][Full Text] [Related]
50. Fluorescence analysis of a tumor model in the chorioallantoic membrane used for the evaluation of different photosensitizers for photodynamic therapy.
Buzzá HH; Zangirolami AC; Davis A; Gómez-García PA; Kurachi C
Photodiagnosis Photodyn Ther; 2017 Sep; 19():78-83. PubMed ID: 28465164
[TBL] [Abstract][Full Text] [Related]
51. Comparison of Physical Pretreatment Regimens to Enhance Protoporphyrin IX Uptake in Photodynamic Therapy: A Randomized Clinical Trial.
Bay C; Lerche CM; Ferrick B; Philipsen PA; Togsverd-Bo K; Haedersdal M
JAMA Dermatol; 2017 Apr; 153(4):270-278. PubMed ID: 28146245
[TBL] [Abstract][Full Text] [Related]
52. A study of concentration changes of Protoporphyrin IX and Coproporphyrin III in mixed samples mimicking conditions inside cancer cells for Photodynamic Therapy.
Landes R; Illanes A; Goeppner D; Gollnick H; Friebe M
PLoS One; 2018; 13(8):e0202349. PubMed ID: 30169536
[TBL] [Abstract][Full Text] [Related]
53. Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: A comparative study.
Lima CA; Goulart VP; Bechara EJ; Correa L; Zezell DM
J Biophotonics; 2016 Dec; 9(11-12):1355-1361. PubMed ID: 27653310
[TBL] [Abstract][Full Text] [Related]
54. Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation.
Kleemann D; MacRobert AJ; Mentzel T; Speight PM; Bown SG
Br J Cancer; 1996 Jul; 74(1):49-58. PubMed ID: 8679457
[TBL] [Abstract][Full Text] [Related]
55. Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatment.
Schimanski A; Ebbert L; Sabel MC; Finocchiaro G; Lamszus K; Ewelt C; Etminan N; Fischer JC; Sorg RV
J Photochem Photobiol B; 2016 Oct; 163():203-10. PubMed ID: 27588717
[TBL] [Abstract][Full Text] [Related]
56. Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy.
Boere IA; Robinson DJ; de Bruijn HS; van den Boogert J; Tilanus HW; Sterenborg HJ; de Bruin RW
Photochem Photobiol; 2003 Sep; 78(3):271-7. PubMed ID: 14556314
[TBL] [Abstract][Full Text] [Related]
57. In vivo pharmacokinetics of 8-aminolevulinic acid-induced protoporphyrin IX during pre- and post-photodynamic therapy in 7,12-dimethylbenz(a)nthracene-treated skin carcinogenesis in Swiss mice: a comparison by three-compartment model.
Diagaradjane P; Madhuri S; Aruna P; Gupta PK; Ganesan S
Photochem Photobiol; 2002 Jul; 76(1):81-90. PubMed ID: 12126311
[TBL] [Abstract][Full Text] [Related]
58. Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma.
Qin J; Zhou C; Zhu M; Shi S; Zhang L; Zhao Y; Li C; Wang Y; Wang Y
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101907. PubMed ID: 32619712
[TBL] [Abstract][Full Text] [Related]
59. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
60. Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.
Yang X; Palasuberniam P; Myers KA; Wang C; Chen B
Oncotarget; 2016 Sep; 7(36):57798-57810. PubMed ID: 27527860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
